Cancer poses a severe health crisis in Iran, particularly for children, with families facing immense financial burdens for treatment. Alireza Varasteh, CEO of the Khorasan Institute for Supporting Children with Cancer, reported 20 new patient registrations monthly, many forced to abandon treatment due to costs. The price of crucial medications, like Nelarabine for leukemia, has surged by 127%. Additionally, inadequate hospital conditions have led to preventable infections, risking young patients’ lives. Systematic corruption exacerbates the issue, diverting medicines to the black market. Urgent reforms are needed, including financial assistance and enhanced healthcare infrastructure, to alleviate this humanitarian emergency.